Equillium Inc.

Clinical research is focused on acute graft-versus-host disease, a serious immune complication that can occur after bone marrow transplantation or hematopoietic stem cell transplantation. The trial activity centers on initial treatment strategies for controlling early inflammatory disease expression.

• Immune-mediated transplant complications
• Allogeneic stem cell transplantation
• Corticosteroid-based therapy

Research interest in this area reflects a therapeutic focus on improving management of transplant-related graft-versus-host disease through targeted immunomodulatory approaches.